Lawson Macartney - Apr 24, 2023 Form 4 Insider Report for Viking Therapeutics, Inc. (VKTX)

Role
Director
Signature
/s/ Michael Morneau as Attorney-in-Fact
Stock symbol
VKTX
Transactions as of
Apr 24, 2023
Transactions value $
-$298,781
Form type
4
Date filed
4/24/2023, 07:31 PM
Previous filing
Apr 18, 2023
Next filing
May 18, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VKTX Common Stock, par value $0.00001 per share Options Exercise $53.3K +16K +33.36% $3.33* 64K Apr 24, 2023 Direct F1
transaction VKTX Common Stock, par value $0.00001 per share Sale -$352K -16K -25.01% $22.00 48K Apr 24, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VKTX Stock Option (Right to Buy) Options Exercise $0 -16K -100% $0.00* 0 Apr 24, 2023 Common Stock 16K $3.33 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.